Publicacións en colaboración con investigadores/as de Hospital Universitario 12 de Octubre (178)

2024

  1. Assessing the clinical benefit, safety, and patient-reported outcomes with the use of the PAHcare™ digital platform in pulmonary arterial hypertension: a pilot study

    Frontiers in Public Health, Vol. 12

  2. Comment on the article titled “Impact of sex on outcome after pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension” published by J. Chan et al

    Journal of Heart and Lung Transplantation

  3. Fluconazole-resistant Candida parapsilosis genotypes from hospitals located in five Spanish cities and one in Italy: Description of azole-resistance profiles associated with the Y132F ERG11p substitution

    Mycoses, Vol. 67, Núm. 3

  4. Real-World Management of Patients with Pulmonary Arterial Hypertension: Insights from EXPOSURE

    Advances in Therapy, Vol. 41, Núm. 3, pp. 1103-1119

  5. Risk Stratification in Pulmonary Veno-Occlusive Disease

    Archivos de Bronconeumologia, Vol. 60, Núm. 5, pp. 321-323

  6. Simplified risk stratification based on cardiopulmonary exercise test: A Spanish two-center experience

    Pulmonary Circulation, Vol. 14, Núm. 1

  7. The importance of data in Pulmonary Arterial Hypertension: from international registries to Machine Learning

    Medicina Clinica

  8. Value of exercise right heart catheterization in the differential diagnosis of chronic thromboembolic pulmonary disease

    Revista Espanola de Cardiologia, Vol. 77, Núm. 2, pp. 158-166

2023

  1. 2022 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

    The European respiratory journal, Vol. 61, Núm. 1

  2. Antifungal resistance in Candida spp within the intra-abdominal cavity: study of resistance acquisition in patients with serial isolates

    Clinical Microbiology and Infection, Vol. 29, Núm. 12, pp. 1604.e1-1604.e6

  3. Chronic Whipple's disease, a diagnostic challenge for the cardiologist

    Revista Espanola de Cardiologia, Vol. 76, Núm. 12, pp. 954-955

  4. Correction: Díaz-García et al. Candida Genotyping of Blood Culture Isolates from Patients Admitted to 16 Hospitals in Madrid: Genotype Spreading during the COVID-19 Pandemic Driven by Fluconazole-Resistant C. parapsilosis. J. Fungi 2022, 8, 1228

    Journal of Fungi

  5. Double lung transplantation in pulmonary arterial hypertension associated with congenital heart disease

    Revista espanola de cardiologia (English ed.), Vol. 76, Núm. 2, pp. 132-134

  6. ECMO in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension as a bridge to therapy

    Kardiologia polska, Vol. 81, Núm. 5, pp. 500-504

  7. Effectiveness and Safety of Balloon Pulmonary Angioplasty for the Treatment of Patients with Persistent Pulmonary Hypertension after Pulmonary Endarterectomy

    Journal of Clinical Medicine, Vol. 12, Núm. 3

  8. Effectiveness and persistence with selexipag in pulmonary arterial hypertension in the real-life setting

    European Journal of Internal Medicine

  9. European Society of Cardiology quality indicators for the care and outcomes of adults with pulmonary arterial hypertension. Developed in collaboration with the Heart Failure Association of the European Society of Cardiology

    European Journal of Heart Failure, Vol. 25, Núm. 4, pp. 469-477

  10. Non-Candida isolates from blood cultures and intra-abdominal samples: data derived from a multicentre prospective study conducted in Madrid

    Revista Espanola de Quimioterapia

  11. Novel Loss-of-Function KCNA5 Variants in Pulmonary Arterial Hypertension

    American Journal of Respiratory Cell and Molecular Biology, Vol. 69, Núm. 2, pp. 147-158

  12. Outcome of moderate-severe tricuspid regurgitation after pulmonary endarterectomy or balloon pulmonary angioplasty

    Revista Espanola de Cardiologia, Vol. 76, Núm. 10, pp. 774-782